STOCK TITAN
  1. Home
  2. Sec-filings
  3. JBIO
  4. [EFFECT] Jade Biosciences, Inc. SEC Filing

[EFFECT] Jade Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 19, 2025 4:00 P.M.
Form: S-1
CIK: 0001798749
Company Name: Jade Biosciences, Inc.
File Number: 333-291541

Source: View Original Filing on SEC EDGAR

Stock JBIO logo
Jade Biosciences Inc

NASDAQ:JBIO

JBIO Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

JBIO Latest News

Jan 5, 2026
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Dec 15, 2025
Jade Biosciences Announces $45 Million Private Placement
Nov 13, 2025
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 8, 2025
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
Nov 3, 2025
Jade Biosciences to Participate in Upcoming Conferences

JBIO Latest SEC Filings

Dec 15, 2025
[8-K] Jade Biosciences, Inc. Reports Material Event
Nov 14, 2025
[10-Q] Jade Biosciences, Inc. Quarterly Earnings Report
Nov 14, 2025
[8-K] Jade Biosciences, Inc. Reports Material Event
Oct 8, 2025
[Form 4] Jade Biosciences, Inc. Insider Trading Activity
Oct 8, 2025
[SCHEDULE 13D/A] Jade Biosciences, Inc. SEC Filing

JBIO Stock Data

653.41M
43.57M
0.04%
99%
5.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM